Back to Search
Start Over
Montelukast: Pharmacology, Safety, Tolerability and Efficacy
- Source :
- Clinical Medicine Insights: Therapeutics, Vol 1 (2009)
- Publication Year :
- 2009
- Publisher :
- SAGE Publishing, 2009.
-
Abstract
- Allergic rhinitis and asthma are common disorders effecting large percentages of the population of Western countries. There are multiple treatment options available for allergic rhinitis and asthma and stepwise approaches to therapy have been recommended. Montelukast is a cysteinyl leukotriene receptor antagonist that has been found to be effective both in the treatment of allergic rhinitis and asthma. This paper will describe the pharmacology, safety, efficacy and tolerability of montelukast. It will examine the comparative efficacy of montelukast to other medications for the treatment of allergic rhinitis and asthma, as well as discuss the recent studies of combination therapy.
- Subjects :
- Drug
education.field_of_study
Combination therapy
business.industry
media_common.quotation_subject
Population
lcsh:RM1-950
Pharmacy
General Medicine
Disease
Pharmacology
medicine.disease
respiratory tract diseases
lcsh:Therapeutics. Pharmacology
Tolerability
immune system diseases
medicine
business
education
Montelukast
hormones, hormone substitutes, and hormone antagonists
Asthma
medicine.drug
media_common
Subjects
Details
- Language :
- English
- Volume :
- 1
- Database :
- OpenAIRE
- Journal :
- Clinical Medicine Insights: Therapeutics
- Accession number :
- edsair.doi.dedup.....10a4308997a2d3a974775e203cc27863